Use of medications and risk of revision after primary total hip arthroplasty.
Elverdalsvej 129, Højbjerg, Denmark. tt@dce.au.dk
Theis Muncholm
TM
Thillemann
D000818:Animals; D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects; D001842:Bone and Bones / Q000187:drug effects*; D004164:Diphosphonates / Q000494:pharmacology*; D004232:Diuretics / Q000009:adverse effects / Q000494:pharmacology*; D017102:Fracture Healing / Q000187:drug effects; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D011379:Prognosis
D004164:Diphosphonates; D004232:Diuretics; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors